Calling $EOLS #investors and analysts 📢 Join us for Evolus’ Investor Day on Thursday, September 12, 8 AM - 12 PM ET in #NYC or virtually. Our management team will provide in-depth presentations and discussions of our strategic vision, growth levers, and financial outlook, followed by a Q&A session. Register here: https://lnkd.in/eTqAxXFr Click here to read the full release: https://lnkd.in/evmYYbnR #Aesthetics #PerformanceBeauty #Fillers #Neurotxins
Evolus
Wellness and Fitness Services
Newport Beach, California 20,555 followers
Evolus is a performance beauty company dedicated to providing extended choices in aesthetic treatments and procedures.
About us
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products. At Evolus, you have the opportunity to be part of a movement. A performance beauty company changing the game. We are bringing innovation and forward-thinking technology to an industry desperately wanting frictionless experiences. Our work disrupts the status quo, but most importantly, we will make an impact, we are customer-centric - always. Because of this, we are excited to step through the door each morning. We help each other climb; we don't climb over one another. We believe that integrity and a team-driven environment connect entrepreneurial minds. Getting goose bumps? Good. Join the Evolus movement, and let's see where you can put your talents to work.
- Website
-
https://www.evolus.com/
External link for Evolus
- Industry
- Wellness and Fitness Services
- Company size
- 51-200 employees
- Headquarters
- Newport Beach, California
- Type
- Public Company
- Founded
- 2014
Locations
-
Primary
520 Newport Center Dr
Newport Beach, California 92660, US
Employees at Evolus
Updates
-
We’re at the Aesthetics 2024 Congress in Sydney, Australia! Dr. Rui Avelar is heading down under, joining a stellar line up to introduce Evolus. With Dr. David Eccleston, Dr. Kristine Romine, and Dr. Cara MacDonald and the new Evolus Australia team, it’s time to start a conversation on evolving the future of beauty.
-
Today, we reported our Q2 2024 financials. Our management team will hold a conference call to discuss the results today at 4:30 p.m. ET. Read the release and access the conference call link here: https://lnkd.in/gnr7VSUu $EOLS #Aesthetics #PerformanceBeauty #EvolveWithUs
-
G’day! We’re really pleased to share that our latest country operations have started up! Welcome Evolus Australia. We are expanding our international presence to this dynamic and fast growing #aesthetic market, supporting our goal of market growth worldwide. We look forward to evolving the future of #PerformanceBeauty with our Australian customers. Read the full press release: https://lnkd.in/eXgYjkSu Post intended for US media and investors. $EOLS #EvolveWithUs #MedicalAesthetics #PerformanceBeauty
-
Excited to share that Evolus will be participating in the Canaccord Genuity Group Inc.'s 44th Annual Growth Conference! Join us on August 13th at 12:30pm ET as our CFO Sandra Beaver will share her perspective on Evolus' innovation and growth strategies. Tune in to the fireside chat here: https://lnkd.in/eUx6nmpZ $EOLS
-
Excited to see Evolus’ neurotoxin featured in NewBeauty’s coverage of the 2023 American Society of Plastic Surgeons (ASPS) report! Our CEO David Moatazedi’s insights on the growing demand for injectable procedures highlight our commitment to innovation and excellence in medical #aesthetics. Proud to be at the forefront of a revolution in #PerformanceBeauty! https://lnkd.in/eiubVt3u #Evolus #EvolveWithUs #MedicalAesthetics #PerformanceBeauty
-
Today we announced the appointment of Albert White, President and Chief Executive Officer of The Cooper Companies, Inc. as the newest member to the Evolus Board of Directors. “We are pleased to welcome Al White to the Evolus Board. Al’s extensive leadership experience, industry knowledge, and proven track record of building a leading medical technology company will be a valuable resource as Evolus embarks on a path from a single-product aesthetics company to a multi-product performance beauty innovator. His expertise will help Evolus further its strategy and aid in our focus on delivering long-term shareholder value.” Vikram Malik, Chairman of the Board of Directors https://lnkd.in/eSHJGy-7
-
We are pleased to announce the submission of the premarket approval (PMA) application to the U.S. Food and Drug Administration for our two dermal filler products for the nasolabial fold. This submission is a key fundamental milestone for Evolus and we remain on track with approval expected in the second half of 2025. https://lnkd.in/eCS_7wCH #EvolveWithUs #PerformanceBeauty $EOLS
-
We’ve shaped our brand around the needs of today’s consumers, who are and will continue to be largely comprised of the millennial generation. Both consumers and injectors have expressed a desire for #aesthetics solutions that are convenient and fit seamlessly into existing beauty routines with little downtime. As we grow our portfolio, our focus will always be bringing innovation into the #MedicalAesthetics space - in technology, our products, and the way we partner with our customers. https://lnkd.in/gvnU5td7 #EvolveWithUs #PerformanceBeauty $EOLS
-
Hola! We’re pleased to announce that we are launching our flagship product in Spain. We are expanding our international presence to one of Europe's largest #aesthetic markets, supporting our goal of market growth worldwide. We look forward to evolving the future of #PerformanceBeauty with our Spanish customers. Read the full press release: https://lnkd.in/eRxn23tG Post intended for US media and investors. $EOLS #Evolus #EvolveWithUs #MedicalAesthetics #PerformanceBeauty